Age-dependent ferritin elevations and HFE C282Y mutation as risk factors for symptomatic knee osteoarthritis in males: A longitudinal cohort study

BMC Musculoskeletal Disorders

Volumn 15, Issue 1, 2014, Pages

  Kennish, Lauren ^a   Attur, Mukundan ^a   Oh, Cheongeun ^a   Krasnokutsky, Svetlana ^a   Samuels, Jonathan ^a   Greenberg, Jeffrey D ^a   Huang, Xi ^a   Abramson, Steven B ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Hemochromatosis; Hypoxia inducible factor; Iron; Osteoarthritis; Radiographic progression

Indexed keywords

FERRITIN; IRON;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; HEMOCHROMATOSIS FE GENE; HUMAN; IRON STORAGE; JOINT CAVITY; KNEE FUNCTION; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROGNOSIS; SEX RATIO; VERY ELDERLY; WEIGHT BEARING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; FERRITINS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KNEE JOINT; LINEAR MODELS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; ODDS RATIO; OSTEOARTHRITIS, KNEE; PHENOTYPE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; UP-REGULATION;

EID: 84892186373     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-15-8     Document Type: Article

References (46)

1. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Arthritis Rheum 2008 58 1 15 25 10.1002/art.23177 18163481
2. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA, Arthritis Rheum 2009 60 12 3546 3553 10.1002/art.24984 19950287
3. Osteoarthritis: a tale of three tissues. Samuels J, Krasnokutsky S, Abramson SB, Bull NYU Hosp Jt Dis 2008 66 3 244 250 18937640
4. Developments in the scientific understanding of osteoarthritis. Abramson SB, Attur M, Arthritis Res Ther 2009 11 3 227 10.1186/ar2655 19519925
5. Osteoarthritis. Goldring MB, Goldring SR, J Cell Physiol 2007 213 3 626 634 10.1002/jcp.21258 17786965
6. Reliability of serum assays of iron status in postmenopausal women. Zeleniuch-Jacquotte A, Zhang Q, Dai J, Shore RE, Arslan AA, Koenig KL, et al. Ann Epidemiol 2007 17 5 354 358 10.1016/j.annepidem.2006.07.004 17027294
7. Reliability of serum iron, ferritin, nitrite, and association with risk of renal cancer in women. Ali MA, Akhmedkhanov A, Zeleniuch-Jaquotte A, Toniolo P, Frenkel K, Huang X, Cancer Detect Prev 2003 27 2 116 121 10.1016/S0361- 090X(03)00027-8 12670522
8. Iron and menopause: does increased iron affect the health of postmenopausal women? Jian J, Pelle E, Huang X, Antioxid Redox Signal 2009 11 12 2939 2943 10.1089/ars.2009.2576 19527179
9. Iron-regulatory proteins: molecular biology and pathophysiological implications. Cairo G, Recalcati S, Expert Rev Mol Med 2007 9 33 1 13
10. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Milman N, Pedersen P, Steig T, Byg KE, Graudal N, Fenger K, Ann Hematol 2001 80 12 737 744 10.1007/s002770100371 11797115
11. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM, Am Heart J 2000 140 1 98 104 10.1067/mhj.2000.106646 10874269
12. Genetic mechanisms and modifying factors in hereditary hemochromatosis. Weiss G, Nat Rev Gastroenterol Hepatol 2010 7 1 50 58 10.1038/nrgastro.2009.201 19918260
13. HFE gene and hereditary hemochromatosis: a HuGE review. Human genome epidemiology. Hanson EH, Imperatore G, Burke W, Am J Epidemiol 2001 154 3 193 206 10.1093/aje/154.3.193 11479183
14. Prevalence of hereditary hemochromatosis in 16031 primary care patients. Phatak PD, Sham RL, Raubertas RF, Dunnigan K, O'Leary MT, Braggins C, et al. Ann Intern Med 1998 129 11 954 961 9867748
15. The genetic epidemiology of osteoarthritis. Valdes AM, Spector TD, Curr Opin Rheumatol 2010 22 2 139 143 10.1097/BOR.0b013e3283367a6e 20090528
16. Ferritin concentrations in synovial fluid are higher in osteoarthritis patients with HFE gene mutations (C282Y or H63D). Carroll GJ, Sharma G, Upadhyay A, Jazayeri JA, Scand J Rheumatol 2010 39 5 413 420 10.3109/03009741003677449 20560808
17. Synovial fluid and plasma selenium, copper, zinc, and iron concentrations in patients with rheumatoid arthritis and osteoarthritis. Yazar M, Sarban S, Kocyigit A, Isikan UE, Biol Trace Elem Res 2005 106 2 123 132 10.1385/BTER:106:2:123 16116244
18. Haemophilic arthropathy resembles degenerative rather than inflammatory joint disease. Roosendaal G, van Rinsum AC, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW, Histopathology 1999 34 2 144 153 10.1046/j.1365-2559.1999.00608. x 10064394
19. Primary osteoarthritis in the ankle joint is associated with finger metacarpophalangeal osteoarthritis and the H63D mutation in the HFE gene: evidence for a hemochromatosis-like polyarticular osteoarthritis phenotype. Carroll GJ, J Clin Rheumatol 2006 12 3 109 113 10.1097/01.rhu.0000221800.77223. d6 16755236
20. The common HFE variants C282Y and H63D are not associated with primary OA of the hip or knee. Loughlin J, Carr A, Chapman K, J Rheumatol 2005 32 2 391 392 15693075
21. Hereditary hemochromatosis as a risk factor for joint replacement surgery. Sahinbegovic E, Dallos T, Aigner E, Axmann R, Engelbrecht M, Schoniger-Hekele M, et al. Am J Med 2010 123 7 659 662 10.1016/j.amjmed.2010.01. 024 20609690
22. Musculoskeletal disease burden of hereditary hemochromatosis. Sahinbegovic E, Dallos T, Aigner E, Axmann R, Manger B, Englbrecht M, et al. Arthritis Rheum 2010 62 12 3792 3798 10.1002/art.27712 20722017
23. Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: an in vitro study. Hooiveld MJ, Roosendaal G, van den Berg HM, Bijlsma JW, Lafeber FP, Rheumatology (Oxford) 2003 42 6 784 790 10.1093/rheumatology/keg220 12730540
24. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Muller M, Antioxid Redox Signal 2009 11 1 59 98 10.1089/ars.2008.2104 18976161
25. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Muckenthaler MU, Galy B, Hentze MW, Annu Rev Nutr 2008 28 197 213 10.1146/annurev.nutr.28.061807.155521 18489257
26. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Saito T, Fukai A, Mabuchi A, Ikeda T, Yano F, Ohba S, et al. Nat Med 2010 16 6 678 686 10.1038/nm.2146 20495570
27. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Yang S, Kim J, Ryu JH, Oh H, Chun CH, Kim BJ, et al. Nat Med 2010 16 6 687 693 10.1038/nm.2153 20495569
28. Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency. Sanchez M, Galy B, Muckenthaler MU, Hentze MW, Nat Struct Mol Biol 2007 14 5 420 426 10.1038/nsmb1222 17417656
29. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Arthritis Rheum 1986 29 8 1039 1049 10.1002/art.1780290816 3741515
30. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW, J Rheumatol 1988 15 12 1833 1840 3068365
31. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Ware JE Jr, Sherbourne CD, Med Care 1992 30 6 473 483 10.1097/00005650-199206000-00002 1593914
32. Further development of a physical function scale on a multidimensional health assessment questionnaire (MDHAQ) for standard care of patients with rheumatic diseases. Pincus T, Sokka T, Kautiainen H, J Rheumatol 2005 32 8 1432 1439 16078316
33. Radiological assessment of osteo-arthrosis. Kellgren JH, Lawrence JS, Ann Rheum Dis 1957 16 4 494 502 10.1136/ard.16.4.494 13498604
34. Increased interleukin-1beta gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Attur M, Belitskaya-Levy I, Oh C, Krasnokutsky S, Greenberg J, Samuels J, et al. Arthritis Rheum 2011 63 7 1908 1917 10.1002/art.30360 21717421
35. Atlas of individual radiographic features in osteoarthritis, revised. Altman RD, Gold GE, Osteoarthritis Cartilage 2007 15 Suppl A 1 A56 17320422
36. Determination of iron metabolism-related reference values in a healthy adult population. Van den Bosch G, Van den Bossche J, Wagner C, De Schouwer P, Van De Vyvere M, Neels H, Clin Chem 2001 47 8 1465 1467 11468239
37. Iron stores in 1359, 30- to 60-year-old Danish women: evaluation by serum ferritin and hemoglobin. Milman N, Kirchhoff M, Ann Hematol 1992 64 1 22 27 10.1007/BF01811467 1739756
38. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment. Milman N, Kirchhoff M, Jorgensen T, Ann Hematol 1992 65 2 96 102 10.1007/BF01698138 1511065
39. Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. Carroll GJ, Breidahl WH, Bulsara MK, Olynyk JK, Arthritis Rheum 2011 63 1 286 294 10.1002/art.30094 20954257
40. HFE gene mutations are associated with osteoarthritis in the index or middle finger metacarpophalangeal joints. Carroll GJ, J Rheumatol 2006 33 4 741 743 16583477
41. HFE genotyping demonstrates a significant incidence of hemochromatosis in undifferentiated arthritis. Cauza E, Hanusch-Enserer U, Etemad M, Koller M, Kostner K, Georg P, et al. Clin Exp Rheumatol 2005 23 1 7 12 15789881
42. Hemochromatosis and femoral head aseptic osteonecrosis: a nonfortuitous association? Rollot F, Wechsler B, du Boutin le TH, De GC, Amoura Z, Hachulla E, J Rheumatol 2005 32 2 376 378 15693103
43. Genetic associations in peripheral joint osteoarthritis and spinal degenerative disease: a systematic review. Ryder JJ, Garrison K, Song F, Hooper L, Skinner J, Loke Y, et al. Ann Rheum Dis 2008 67 5 584 591 17720722
44. Increased risk of arthropathies and joint replacement surgery in patients with genetic hemochromatosis: a study of 3,531 patients and their 11,794 first-degree relatives. Elmberg M, Hultcrantz R, Simard JF, Carlsson A, Askling J, Arthritis Care Res (Hoboken) 2013 65 678 685 10.1002/acr.21883 23139229
45. Risk factors for progression of tibiofemoral osteoarthritis: an analysis based on fluoroscopically standardised knee radiography. Mazzuca SA, Brandt KD, Katz BP, Ding Y, Lane KA, Buckwalter KA, Ann Rheum Dis 2006 65 4 515 519 10.1136/ard.2005.039115 16166105
46. Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. Samokyszyn VM, Miller DM, Reif DW, Aust SD, J Biol Chem 1989 264 1 21 26 2535839